Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research  How it helps Latest publication
N-(1,3-Benzodioxol-5-ylmethyl)-6H-indolo[2,3-b]quinoxaline-2-carboxamide
Potential treatment - theoretical effect Experimental Antiviral Dec/04/2020
ACE2-GpA-RBC
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021
Remdesivir
Approved by FDA Experimental Antiviral Jan/18/2023
2-(2,3-Dihydro-1H-indol-1-ylcarbonyl)-N-(3-methylphenyl)quinazolin-4-amine
Potential treatment - theoretical effect Experimental Antiviral Dec/04/2020
RBD-Fc Vacc
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/17/2021
SARS-CoV-2-IN-1
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/09/2020
S2X259
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
BNT162b2
Approved by FDA Experimental Vaccine Jun/22/2022
Aloxistatin
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/27/2021
BBV152
Emergency use authorization Experimental Vaccine Mar/27/2021
S2K146
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/06/2022
S2N28
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
S2GΔHR2 I3-01v9 SApNP
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/19/2021
SΔC-Fer
Potential treatment - pre-clinical evidence Experimental Vaccine Jan/05/2021
RBD-SpyVLP
Potential treatment - pre-clinical evidence Experimental Vaccine Jan/22/2021
Stenoparib
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/19/2021
CR-31-B (-)
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/08/2021
mAb Beta-53
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
sMVA-N/S
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/30/2020
Noscapine
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020